The Gamaleya Center’s preliminary laboratory study shows that Sputnik V demonstrates high virus neutralizing activity (VNA) against the Omicron (B.1.1.529) variant and is expected to provide strong defense against severe disease and hospitalization. The study was conducted using sera with a long period after vaccination (more than 6 months after vaccination) as an indicator of…
| Powered by WordPress | Theme by TheBootstrapThemes